Germana Tognon
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia(IT)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, MicroRNA in disease regulation, Circular RNAs in diseases
Most-Cited Works
- → ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease(2019)1,130 cited
- → Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies(2010)448 cited
- → Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients(2010)132 cited
- → Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management(2011)124 cited
- → HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm(2011)104 cited
- → Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial(2024)94 cited
- → Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease(2007)88 cited
- → Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial(2019)86 cited
- → Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts(2016)83 cited
- → Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome(2012)76 cited